ONLINE
CONTINUING EDUCATION PROGRAMS: HEAD AND
NECK CANCER
EGFR-Targeted Therapies for Head and Neck Cancers
Description Advanced practice oncology nurses will participate in
discussions of challenging cases on EGFR-targeted
therapies for SCCHN. Audience members will have the
opportunity to test their understanding of appropriate
treatment regimens based on current data during an
interactive question-and-answer presentation using
Audience Response System (ARS) keypad technology.
Monograph
Release Date: February 2008
Expiration Date: February 2009 Estimated Time to Complete Activity: 1 hour 0 minutes Credit Hours: 1.3
Emerging Therapies in Head and Neck Cancers: EGFR Inhibitors
Description
The efficacy of conventional therapies for advanced
head and neck cancers is limited and has reached a
plateau. Epidermal growth factor receptor (EGFR)
inhibitors are emerging as promising therapeutic
options for this group of diseases. In this educational
symposium, advancements in the treatment of head
and neck cancers with EGFR inhibitors and the
rationale for the use of these agents will be discussed.
Nursing management of potential side effects and key
aspects of patient education will be highlighted.